Literature DB >> 15723973

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Riccardo Cappato1, Hugh Calkins, Shih-Ann Chen, Wyn Davies, Yoshito Iesaka, Jonathan Kalman, You-Ho Kim, George Klein, Douglas Packer, Allan Skanes.   

Abstract

BACKGROUND: The purpose of this study was to conduct a worldwide survey investigating the methods, efficacy, and safety of catheter ablation (CA) of atrial fibrillation (AF). METHODS AND
RESULTS: A detailed questionnaire was sent to 777 centers worldwide. Data relevant to the study purpose were collected from 181 centers, of which 100 had ongoing programs on CA of AF between 1995 and 2002. The number of patients undergoing this procedure increased from 18 in 1995 to 5050 in 2002. The median number of procedures per center was 37.5 (range, 1 to 600). Paroxysmal AF, persistent AF, and permanent AF were the indicated arrhythmias in 100.0%, 53.0%, and 20.0% of responding centers, respectively. The most commonly used techniques were right atrial compartmentalization between 1995 and 1997, ablation of the triggering focus in 1998 and 1999, and electrical disconnection of multiple pulmonary veins between 2000 and 2002. Of 8745 patients completing the CA protocol in 90 centers, of whom 2389 (27.3%) required >1 procedure, 4550 (52.0%; range among centers, 14.5% to 76.5%) became asymptomatic without drugs and another 2094 (23.9%; range among centers, 8.8% to 50.3%) became asymptomatic in the presence of formerly ineffective antiarrhythmic drugs over an 11.6+/-7.7-month follow-up period. At least 1 major complication was reported in 524 patients (6.0%).
CONCLUSIONS: The findings of this survey provide a picture of the variable and evolving methods, efficacy, and safety of CA for AF as practiced in a large number of centers worldwide and may serve as a guide to clinicians considering therapeutic options in patients suffering from this arrhythmia.

Entities:  

Mesh:

Year:  2005        PMID: 15723973     DOI: 10.1161/01.CIR.0000157153.30978.67

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  333 in total

1.  Different strategies for performing pulmonary vein isolation in patients with pulmonary vein rhythm.

Authors:  Michifumi Tokuda; Teiichi Yamane; Seiichiro Matsuo; Keiichi Ito; Ryohsuke Narui; Mika Hioki; Shin-Ichi Tanigawa; Tokiko Nakane; Seigo Yamashita; Keiichi Inada; Kenri Shibayama; Satoru Miyanaga; Hiroshi Yoshida; Hidekazu Miyazaki; Taro Date; Ken-Ichi Sugimoto; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2011-01-28       Impact factor: 2.037

Review 2.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

3.  Clinical indications for cardiac computed tomography. From the Working Group of the Cardiac Radiology Section of the Italian Society of Medical Radiology (SIRM).

Authors:  E di Cesare; I Carbone; A Carriero; M Centonze; F De Cobelli; R De Rosa; P Di Renzi; A Esposito; R Faletti; R Fattori; M Francone; A Giovagnoni; L La Grutta; G Ligabue; L Lovato; R Marano; M Midiri; L Natale; A Romagnoli; V Russo; F Sardanelli; F Cademartiri
Journal:  Radiol Med       Date:  2012-04-01       Impact factor: 3.469

4.  Towards a paradigm shift in atrial fibrillation.

Authors:  H J G M Crijns
Journal:  Neth Heart J       Date:  2010-08       Impact factor: 2.380

5.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women.

Authors:  David Conen; Paul M Ridker; Brendan M Everett; Usha B Tedrow; Lynda Rose; Nancy R Cook; Julie E Buring; Christine M Albert
Journal:  Eur Heart J       Date:  2010-05-25       Impact factor: 29.983

6.  Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation.

Authors:  Jan W Schrickel; Markus Linhart; Dietmar Bänsch; Daniel Thomas; Georg Nickenig
Journal:  Clin Res Cardiol       Date:  2015-10-29       Impact factor: 5.460

Review 7.  [Catheter ablation and the complications].

Authors:  D Steven; J H van den Bruck; T Plenge; J Lüker; A Sultan
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-12

8.  Catheter ablation of permanent atrial fibrillation: medium term results.

Authors:  M J Earley; D J R Abrams; A D Staniforth; S C Sporton; R J Schilling
Journal:  Heart       Date:  2005-08-23       Impact factor: 5.994

9.  Safety and efficacy outcomes of protamine administration for heparin reversal following cryoballoon-based pulmonary vein isolation.

Authors:  Kadri Murat Gurses; Duygu Kocyigit; Muhammed Ulvi Yalcin; Banu Evranos; Hikmet Yorgun; Mehmet Levent Sahiner; Ergun Baris Kaya; Mehmet Ali Oto; Necla Ozer; Kudret Aytemir
Journal:  J Interv Card Electrophysiol       Date:  2015-02-28       Impact factor: 1.900

10.  Delayed cardiac tamponade 8 months after pulmonary vein isolation.

Authors:  Tetsuo Yamanaka; Toru Fukatsu; Tatsuya Kamon; Satoshi Kitahara; Yoshimaro Ichinohe; Hirotaka Komatsu; Yasunobu Hirata
Journal:  J Cardiol Cases       Date:  2017-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.